Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Oct 30, 2014, during market hours
10-Q filed Oct 30, 2014, 30 days after period end · 0001396814-14-000013
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $52.05M | $23.26M | $8.49M | $3.96M |
| Net Income | -$3.00M | -$14.78M | -$15.75M | -$9.51M |
| EPS Diluted | -$0.08 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.44 |
| -$0.49 |
| -$0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.